Affinity Asset Advisors, LLC: summary

Affinity Asset Advisors, LLC reported 121 positions with a reported value of $2.46B in its 13F for Q3 2026. Compared with Q2 2026: 33 new positions, 25 exited.

Top positions

• ISHARES RUSSELL 2000 ETF
• ROIVANT SCIENCES LTD SHS
• Spyre Therapeutics Inc
• STATE STREET SPDR S&P BIOTECH ETF
• Erasca Inc
• First Tracks Biotherapeutics, Inc.
• Xenon Pharmaceuticals Inc
• INSMED INC
• ALKERMES PLC
• MODERNA INC COM